Linde PLC $LIN Shares Bought by Flossbach Von Storch SE

Flossbach Von Storch SE lifted its position in shares of Linde PLC (NASDAQ:LIN) by 97.3% in the third quarter, HoldingsChannel.com reports. The institutional investor owned 721,959 shares of the basic materials company’s stock after buying an additional 355,950 shares during the quarter. Linde accounts for approximately 1.4% of Flossbach Von Storch SE’s holdings, making the stock its 27th largest position. Flossbach Von Storch SE’s holdings in Linde were worth $342,931,000 as of its most recent SEC filing.

Other hedge funds have also recently bought and sold shares of the company. Darwin Wealth Management LLC acquired a new stake in shares of Linde during the second quarter worth $25,000. Marquette Asset Management LLC purchased a new position in Linde during the third quarter worth about $27,000. YANKCOM Partnership boosted its stake in Linde by 195.2% in the 3rd quarter. YANKCOM Partnership now owns 62 shares of the basic materials company’s stock worth $29,000 after buying an additional 41 shares during the last quarter. Albion Financial Group UT boosted its stake in Linde by 87.8% in the 3rd quarter. Albion Financial Group UT now owns 77 shares of the basic materials company’s stock worth $37,000 after buying an additional 36 shares during the last quarter. Finally, Howard Hughes Medical Institute purchased a new stake in Linde in the 2nd quarter valued at about $48,000. Institutional investors and hedge funds own 82.80% of the company’s stock.

Wall Street Analyst Weigh In

Several research analysts have recently weighed in on LIN shares. JPMorgan Chase & Co. cut their price objective on shares of Linde from $475.00 to $455.00 and set an “overweight” rating on the stock in a report on Monday, November 3rd. Citigroup increased their price target on shares of Linde from $520.00 to $540.00 and gave the stock a “buy” rating in a research note on Wednesday, January 21st. CICC Research assumed coverage on shares of Linde in a report on Wednesday, December 3rd. They issued an “outperform” rating and a $510.00 price target on the stock. Royal Bank Of Canada dropped their price objective on Linde from $540.00 to $490.00 and set an “outperform” rating for the company in a report on Friday, December 12th. Finally, Mizuho set a $495.00 target price on Linde in a report on Thursday, December 11th. One research analyst has rated the stock with a Strong Buy rating, six have assigned a Buy rating and one has given a Hold rating to the company’s stock. According to data from MarketBeat, the stock has an average rating of “Buy” and a consensus price target of $501.75.

Linde Price Performance

LIN opened at $451.50 on Thursday. Linde PLC has a 52-week low of $387.78 and a 52-week high of $486.38. The company has a 50 day moving average of $424.00 and a two-hundred day moving average of $447.95. The company has a market cap of $210.83 billion, a P/E ratio of 30.24, a P/E/G ratio of 3.18 and a beta of 0.85. The company has a quick ratio of 0.69, a current ratio of 0.82 and a debt-to-equity ratio of 0.46.

Linde (NASDAQ:LIN) last posted its earnings results on Friday, October 31st. The basic materials company reported $4.21 earnings per share for the quarter, beating the consensus estimate of $4.18 by $0.03. Linde had a net margin of 21.17% and a return on equity of 19.38%. The business had revenue of $8.62 billion for the quarter, compared to analyst estimates of $8.62 billion. During the same quarter in the previous year, the business posted $3.94 EPS. The business’s quarterly revenue was up 2.9% on a year-over-year basis. Linde has set its FY 2025 guidance at 16.350-16.450 EPS and its Q4 2025 guidance at 4.100-4.200 EPS. On average, analysts expect that Linde PLC will post 16.54 earnings per share for the current year.

Linde Company Profile

Linde (NASDAQ: LIN) is a multinational industrial gases and engineering company that supplies gases, related technologies and services to a wide range of industries. The company traces its current form to the 2018 combination of Germany’s Linde AG and U.S.-based Praxair, creating one of the largest global providers of industrial, specialty and medical gases. Linde’s business model centers on production, processing and distribution of gases as well as the design and construction of the plants and equipment needed to produce them.

Core products and services include atmospheric and process gases such as oxygen, nitrogen and argon; hydrogen and helium; carbon dioxide; and a portfolio of higher‑value specialty and electronic gases.